Discover how integrated psychotherapy—CBTp, family support, and relapse plans—boosts schizophrenia recovery alongside antipsychotics.
|Podcasts|September 14, 2011
Treating Prodromal Symptoms of Psychosis
Author(s)Irene M. Hurford, MD
Listen
0:00 / 0:00
A review of some of the latest study findings on the pharmacological treatment of prodromal psychosis.
Advertisement
What are the pros and cons of treating subtreshold high-risk psychotic symptoms? Does early intervention help or hinder patient outcomes? Can conversion to psychosis be delayed or prevented? Dr Hurford reviews some of the latest study findings on the pharmacological treatment of prodromal psychosis.
Dr Hurford is Assistant Professor in the Department of Psychiatry at the University of Pennsylvania.
Treating Prodromal Symptoms of Psychosis
Advertisement
Related to this article
A case report and review of 13 similar cases suggest that late-onset clozapine neutropenia may sometimes reflect neutrophil margination rather than marrow suppression, with corticosteroids, granulocyte colony-stimulating factor, or lithium as possible, carefully monitored paths to continuing treatment.
Medicare claims show pimavanserin in Parkinson psychosis nursing homes links to fewer falls and recurrent falls than quetiapine or other antipsychotics.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Top 7 Atypical Psychedelics: A Brief Clinical Guide
2
Positive Phase 1b Results Demonstrate Clinical Proof-of-Concept for ALKS 7290 in Adults With ADHD
3
Positive Topline Phase 3 Study Results: Lumateperone for Manic Episodes in Bipolar I Disorder
4
New Analyses of HLP003 for the Adjunctive Treatment of MDD
5